Carglumic acid

Chemical formula: C₆H₁₀N₂O₅  Molecular mass: 190.154 g/mol  PubChem compound: 121396

Therapeutic indications

Carglumic acid is indicated for:

Hyperammonemia

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Carglumic acid is indicated in treatment of:

  • hyperammonaemia due to N-acetylglutamate synthase primary deficiency.
  • hyperammonaemia due to isovaleric acidaemia.
  • hyperammonaemia due to methymalonic acidaemia.
  • hyperammonaemia due to propionic acidaemia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Carglumic acid is contraindicated in the following cases:

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: CARBAGLU Dispersible tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈